Formulation and Characterization of Orally Dissolving Thin Films containing the German cockroach Blatella germanica (Bla g 2) Allergen
- PMID: 33880385
- PMCID: PMC8055048
Formulation and Characterization of Orally Dissolving Thin Films containing the German cockroach Blatella germanica (Bla g 2) Allergen
Abstract
Allergy and asthma are among the most common chronic diseases of childhood. Cockroach allergy is an important contributor to asthma morbidity, with a prevalence of 17 to 41%. Immunotherapy has been shown to be an effective treatment for other allergies that contribute to asthma, but several factors have limited its use for cockroach allergy. In this work, a sublingual immunotherapy (SLIT) formulation of orally dissolving thin film has been developed for the treatment of hypersensitivity to the German cockroach Bla g 2 allergen. The formulation allows for the incorporation of up to 25 μg/film of the allergen protein, and the film's mucoadhesiveness prolongs the effect of the allergen with the potential for enhanced efficacy. The potency and dose uniformity of the SLIT formulation were characterized by enzyme-linked immunosorbent assay (ELISA), and other physicochemical properties were evaluated by spectroscopic or mechanistic methods. The films were uniform in weight and thickness, and demonstrated substantial physical strength to allow easy manipulation during manufacturing and dosing. The dosage uniformity, in vitro disintegration and in vitro dissolution profiles of the films were within the acceptance criteria in the United States Pharmacopeia. The developed SLIT methodology possesses the potential to significantly improve immunotherapy for both food and inhalant allergies in adults and children.
Keywords: Bla g 2; Cockroach; ELISA; drug delivery; immunotherapy; thin film.
Figures




Similar articles
-
Extraction, Purification, and Development of Sublingual Film (SLIT Films) Comprising Cockroach Allergen for Treatment of Allergy.Curr Drug Deliv. 2023;20(6):807-817. doi: 10.2174/1567201819666220617122411. Curr Drug Deliv. 2023. PMID: 35718958
-
Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets.Curr Ther Res Clin Exp. 2022 Jun 23;96:100678. doi: 10.1016/j.curtheres.2022.100678. eCollection 2022. Curr Ther Res Clin Exp. 2022. PMID: 35813554 Free PMC article.
-
Bla g 1 allergen levels in Zagreb area household dust.Arh Hig Rada Toksikol. 2011 Mar;62(1):33-9. doi: 10.2478/10004-1254-62-2011-2080. Arh Hig Rada Toksikol. 2011. PMID: 21421531
-
Cockroach allergens: environmental distribution and relationship to disease.Curr Allergy Asthma Rep. 2001 Sep;1(5):466-73. doi: 10.1007/s11882-001-0035-1. Curr Allergy Asthma Rep. 2001. PMID: 11892074 Review.
-
Cockroach allergens and asthma.J Allergy Clin Immunol. 2001 Mar;107(3):419-28. doi: 10.1067/mai.2001.112854. J Allergy Clin Immunol. 2001. PMID: 11240940 Review.
Cited by
-
Cockroach allergy: Understanding complex immune responses to develop novel therapies.Mol Immunol. 2023 Apr;156:157-169. doi: 10.1016/j.molimm.2023.03.001. Epub 2023 Mar 15. Mol Immunol. 2023. PMID: 36930991 Free PMC article.
References
-
- Arruda KL, Vailes L, Ferriani VPL, et al. Cockroach allergies and asthma. J Allergy Clin Immunol. 2001;107(3):419–428. - PubMed
-
- Gruchalla RS, Pongracic J, Plaut M, et al. Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol. 2005;115(3):478–485. - PubMed
-
- Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997;336(19):1356–63. - PubMed
-
- Matsui EC, Wood RA, Rand C, et al. Cockroach allergen exposure and sensitization in suburban middle-class children with asthma. J Allergy Clin Immunol. 2003;112(1):87–92. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources